PATENT CLAIM ANALYSIS

Application Number: 16107385
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["544", "235000"]

Abstract:
Provided herein are compounds and methods of synthesis thereof. The compounds set forth herein are useful for the treatment, prevention, and/or management of various disorders, such as neurological disorders, neurodegenerative disorders, neuropsychiatric disorders, disorders of cognition, learning or memory, gastrointestinal disorders, lower urinary tract disorder, and cancer. Compounds set forth herein modulate the activity of metabotropic glutamate receptor 5 (mGluR5) in the central nervous system or the periphery. Pharmaceutical formulations containing the compounds and their methods of use are also provided herein.

Claim (Index 41):
A method of  claim 39 , wherein the neurological disorder is selected from schizophrenia, psychosis, and a cognitive disorder.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 96.0
- Lexical Diversity: 1.63333
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12972293', '14299364', '14122519', '14124455', '15013741']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7964893970984803
- 35 USC 102 Novelty (BERT): 0.5533573864026187
- Combined Prediction Score: 0.7721761960288942
- Mean Citation Score: 391.818932
- Max Citation Score: 464.89075
- Similarity Product: 261.617261138767

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test